title: Bilateral corneal infection as a complication of laser in situ keratomileusis.
authors.forename: H
authors.initials: H
authors.lastname: Watanabe
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: N
authors.initials: N
authors.lastname: Maeda
authors.forename: Y
authors.initials: Y
authors.lastname: Inoue
authors.forename: Y
authors.initials: Y
authors.lastname: Shimomura
authors.forename: Y
authors.initials: Y
authors.lastname: Tano
mesh_terms: D000293:Adolescent; D015377:Cilastatin / Q000627:therapeutic use; D003315:Cornea / Q000187:drug effects / Q000382:microbiology; D003316:Corneal Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D016039:Corneal Transplantation / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D007275:Injections, Intravenous; D053685:Laser Therapy / Q000009:adverse effects*; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D009824:Ointments; D009883:Ophthalmic Solutions; D011480:Protease Inhibitors / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification
chemical_list: D009824:Ointments; D009883:Ophthalmic Solutions; D011480:Protease Inhibitors; D015377:Cilastatin; D015378:Imipenem; D015242:Ofloxacin